Roberta Depenni

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

Burt Nabors, Karen Fink, Tom Mikkelsen et al. · Neuro-Oncology · 2015 · 235 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

Carmelo Bengala, Federica Bertolini, N. Malavasi et al. · British Journal of Cancer · 2009 · 215 citations · Full text

Medicine, Oncology, Pharmacology +9

Prognostic and Predictive Value of Baseline and Posttreatment Molecular Marker Expression in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy

Federica Bertolini, Carmelo Bengala, Luisa Losi et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 107 citations · Full text

Medicine, Oncology, Surgery +17

Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma

Alice Baggi, Pietro Quaglino, Marco Rubatto et al. · European Journal of Cancer · 2021 · 107 citations

Medicine, Dermatology, Oncology +14

Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy

Sara De Biasi, Lara Gibellini, Domenico Lo Tartaro et al. · Nature Communications · 2021 · 86 citations · Full text

Medicine, Immunology, Oncology +17